Target intelligence / Profile preview

Influenza A virus neuraminidase protein subtype 1 (NA)

Target
NA
Molecular classification
Enzyme, Viral surface glycoprotein, Exosialidase (EC 3.2.1.18)
01

Overview

Influenza A virus neuraminidase protein subtype 1 is a tetrameric viral surface enzyme found on the envelope of influenza A viruses, designated as N1 in virus subtyping (e.g., H1N1). It acts as an exosialidase that cleaves terminal sialic acid residues from host cell surface glycoconjugates, enabling newly formed virus particles to detach and spread from infected cells. Each monomer contains about 470 amino acids and folds into four domains: cytoplasmic tail, transmembrane region, stalk, and catalytic "head," with active sites on the upper surface. Neuraminidase is essential for efficient viral propagation in the host and is a major antigenic determinant used for influenza virus classification. It is a proven therapeutic target, with several inhibitors in clinical use and ongoing challenges relating to resistance and antigenic variability.

Other names
Influenza A neuraminidase N1Neuraminidase N1NASialidase (less commonly)
02

Mechanism of action

Competitive inhibition of the neuraminidase active site, blocking cleavage of sialic acid residues and preventing release of progeny virions from infected cells

03

Biological functions

Cleavage of sialic acid residues from glycoproteins and glycolipidsFacilitation of viral release from host cell surfacePrevention of viral particle aggregationModulation of virus infectivity/finess
04

Disease associations

Infection (Influenza)
05

Safety considerations

Emergence of drug-resistant influenza A strains due to amino acid substitutions in neuraminidaseAntigenic drift/shift, leading to loss of drug efficacy and immune escapeNeed for rapid and accurate subtyping in outbreaks/pandemics
06

Interacting drugs

Oseltamivir (Tamiflu)

2 more in the full profile.

07

Biomarkers

NA antigen and NA inhibition (used to subtype and assess antiviral resistance)Genetic mutations in the neuraminidase gene indicating drug resistance (e.g., H274Y mutation for oseltamivir resistance)

Beyond the preview

Go deeper on Influenza A virus neuraminidase protein subtype 1 (NA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus neuraminidase protein subtype 1 (NA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call